Effect of Low (5 mg) vs. High (20-40 mg) Rosuvastatin Dose on 24h Arterial Stiffness, Central Haemodynamics, and Non-Alcoholic Fatty Liver Disease in Patients with Optimally Controlled Arterial Hypertension.
Τίτλος | Effect of Low (5 mg) vs. High (20-40 mg) Rosuvastatin Dose on 24h Arterial Stiffness, Central Haemodynamics, and Non-Alcoholic Fatty Liver Disease in Patients with Optimally Controlled Arterial Hypertension. |
Publication Type | Journal Article |
Year of Publication | 2018 |
Authors | Mitsiou, E., Boutari C., Kotsis V., Georgianou E., Doumas M., Karagiannis A., & Athyros V. G. |
Journal | Curr Vasc Pharmacol |
Volume | 16 |
Issue | 4 |
Pagination | 393-400 |
Date Published | 2018 |
ISSN | 1875-6212 |
Λέξεις κλειδιά | Adult, Antihypertensive Agents, Arterial Pressure, Female, Greece, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hypertension, Male, Middle Aged, Non-alcoholic Fatty Liver Disease, Prospective Studies, Risk Factors, Risk Reduction Behavior, Rosuvastatin Calcium, Time Factors, Treatment Outcome, Vascular Stiffness |
Abstract | OBJECTIVE: Arterial Stiffness (AS) and Non-Alcoholic Fatty Liver Diseases (NAFLD) are 2 related, prevalent, risk predictors of Cardiovascular Disease (CVD). We assessed the effect of low dose (5 mg/day) vs. high dose (20-40 mg/day) rosuvastatin on aortic elasticity and central haemodynamics as well as on NAFLD in patients with Arterial Hypertension (AH). |
DOI | 10.2174/1570161115666170630122833 |
Alternate Journal | Curr Vasc Pharmacol |
PubMed ID | 28669329 |